Under an ophthalmoscope, some retinas show something unmistakable: tiny, glistening yellow-white deposits scattered across the surface, like scattered crystals. That’s the hallmark of Bietti’s Crystalline Dystrophy, a rare and slow-moving condition reported more often in East Asian populations, though not confined to them — patients from Ethiopia are usually first flagged after a local ophthalmologist spots those characteristic crystals during a routine fundus check.
The crystals themselves aren’t really what causes the vision loss — they’re more of a visible marker. What actually matters is how much of the surrounding retinal tissue has already been affected by the underlying degenerative process, and that’s where our evaluation puts its focus.

Associate Professor, Vitreo-Retina Surgeon. 10+ Years Experience

Senior Consultant Ophthalmologist & Eye Surgeon· 26+ yrs experience

Consultant Ophthalmologist & Eye Surgeon, MD, DO .16+ Years Experience
“Not directly — they function more as a marker than a cause. It’s the thinning of the retina and choroid around them that actually drives the vision decline, and that’s what our evaluation and ongoing monitoring focus on.”
”
Generally quite slowly, often stretched across many years to decades, though the pace does vary between individuals. That’s a big part of why we recommend ongoing periodic monitoring rather than a single one-time check.”
“It’s been reported more often in East Asian populations in the published literature, but it isn’t confined to any one group and does turn up elsewhere, including among patients of Ethiopian and broader African background.”
“The presence of distinctive crystalline deposits on fundus examination, together with confirmation of a CYP4V2 mutation on genetic testing, is what sets Bietti’s Crystalline Dystrophy apart from other rod-cone dystrophies that can otherwise look fairly similar on the surface.”
